The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK plc announced the acquisition of ordinary shares by several key executives under the ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

The gross profit margin for GLAXOSMITHKLINE PLC is currently very high, coming in at 70.72%. Regardless of GSK's high profit margin, it has managed to decrease from the same period last year.

Investors in GlaxoSmithKline plc (NYSE: GSK) saw new options begin trading today, for the August 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay ...

A month has gone by since the last earnings report for GSK (GSK). Shares have added about 3.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up ...

GlaxoSmithKline's Q2 2009 results, released a few days ago, were well received but within the company's disclosures and investor presentations were some sobering statistics on the ...

GlaxoSmithKline is currently sporting a Zacks Rank of #2 (Buy). Over the past 90 days, the Zacks Consensus Estimate for GSK's full-year earnings has moved 0.9% higher.

The U.S. Food and Drug Administration (FDA) has approved an MMR vaccine developed by GlaxoSmithKline for use in America for those above the age of one.

Let's put GlaxoSmithKline plc GSK stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look ...

GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights ...

Investors in GlaxoSmithKline plc (NYSE: GSK) saw new options become available today, for the January 2017 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...